App D: Misuse of Presc. Rx: Data from 2k2, 2k3, & 2k4 NSDUH, SAMHSA, Office of Applied Studies

51020

**Table 2.1AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	46,558	47,882	48,013	14,680	14,986	14,643	6,210	6,336	6,007
Pain Relievers	29,611^a	31,207	31,768	10,992	11,671	11,256	4,377	4,693	4,404
OxyContin^®	1,924^b	2,832	3,072	--	--	1,213	--	--	325
Tranquilizers	19,267	20,220	19,852	4,849	5,051	5,068	1,804	1,830	1,616
Stimulants	21,072	20,798	19,982	3,181	2,751	2,918	1,218	1,191	1,189
Methamphetamine	12,383	12,303	11,726	1,541	1,315	1,440	597	607	583
Sedatives	9,960	9,510	9,891	981	831	737	436^a	294	265
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	19.8	20.1	20.0	6.2	6.3	6.1	2.6	2.7	2.5
Pain Relievers	12.6	13.1	13.2	4.7	4.9	4.7	1.9	2.0	1.8
OxyContin^®	0.8^b	1.2	1.3	--	--	0.5	--	--	0.1
Tranquilizers	8.2	8.5	8.3	2.1	2.1	2.1	0.8	0.8	0.7
Stimulants	9.0^a	8.8	8.3	1.4	1.2	1.2	0.5	0.5	0.5
Methamphetamine	5.3	5.2	4.9	0.7	0.6	0.6	0.3	0.3	0.2
Sedatives	4.2	4.0	4.1	0.4	0.3	0.3	0.2^a	0.1	0.1

51020

**Table 2.2AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	3,389	3,351	3,394	2,283	2,289	2,225	979	997	914
Pain Relievers	2,775	2,798	2,879	1,870	1,917	1,865	794	801	751
OxyContin^®	224^b	254	305	--	--	194	--	--	66
Tranquilizers	834	874	816	568	586	532	188	226^a	161
Stimulants	1,074^b	1,007^a	867	650^b	568	496	200	221	178
Methamphetamine	366	328	299	226^a	174	163	63	69	57
Sedatives	238	249	251	138	131	133	47^a	47	26
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	13.7	13.4	13.5	9.2	9.2	8.8	4.0	4.0	3.6
Pain Relievers	11.2	11.2	11.4	7.6	7.7	7.4	3.2	3.2	3.0
OxyContin^®	0.9^a	1.0	1.2	--	--	0.8	--	--	0.3
Tranquilizers	3.4	3.5	3.2	2.3	2.3	2.1	0.8	0.9^a	0.6
Stimulants	4.3^b	4.0^b	3.4	2.6^b	2.3	2.0	0.8	0.9	0.7
Methamphetamine	1.5^a	1.3	1.2	0.9^a	0.7	0.6	0.3	0.3	0.2
Sedatives	1.0	1.0	1.0	0.6	0.5	0.5	0.2^a	0.2	0.1

51020

**Table 2.3AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	8,587^b	9,211	9,392	4,411^a	4,598	4,751	1,683^b	1,913	1,959
Pain Relievers	6,854^b	7,513	7,813	3,540^a	3,803	3,834	1,262^b	1,486	1,504
OxyContin^®	820^b	1,145^b	1,376	--	--	562	--	--	142
Tranquilizers	3,473^b	3,898	3,919	1,509	1,682	1,658	487	525	566
Stimulants	3,340	3,420	3,426	1,144	1,114	1,181	386	400	446
Methamphetamine	1,756	1,650	1,688	525	506	516	160	185	186
Sedatives	648	565	627	162	156	163	49	58	49
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	27.7^a	29.0	29.2	14.2	14.5	14.8	5.4^a	6.0	6.1
Pain Relievers	22.1^b	23.7	24.3	11.4	12.0	11.9	4.1^a	4.7	4.7
OxyContin^®	2.6^b	3.6^b	4.3	--	--	1.7	--	--	0.4
Tranquilizers	11.2^a	12.3	12.2	4.9	5.3	5.2	1.6	1.7	1.8
Stimulants	10.8	10.8	10.6	3.7	3.5	3.7	1.2	1.3	1.4
Methamphetamine	5.7	5.2	5.2	1.7	1.6	1.6	0.5	0.6	0.6
Sedatives	2.1	1.8	1.9	0.5	0.5	0.5	0.2	0.2	0.2

51020

**Table 2.4AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	34,582	35,320	35,227	7,986	8,099	7,667	3,549	3,426	3,134
Pain Relievers	19,983	20,896	21,076	5,582	5,950	5,556	2,321	2,406	2,149
OxyContin^®	881^b	1,433	1,392	--	--	457	--	--	118
Tranquilizers	14,959	15,447	15,117	2,772	2,783	2,878	1,129	1,078	889
Stimulants	16,658	16,371	15,689	1,387	1,068	1,241	631	570	565
Methamphetamine	10,261	10,325	9,739	790	636	761	375	353	340
Sedatives	9,075	8,696	9,012	681	544	441	340	189	190
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	19.3	19.5	19.2	4.5	4.5	4.2	2.0	1.9	1.7
Pain Relievers	11.1	11.5	11.5	3.1	3.3	3.0	1.3	1.3	1.2
OxyContin^®	0.5^b	0.8	0.8	--	--	0.2	--	--	0.1
Tranquilizers	8.3	8.5	8.3	1.5	1.5	1.6	0.6	0.6	0.5
Stimulants	9.3^a	9.0	8.6	0.8	0.6	0.7	0.4	0.3	0.3
Methamphetamine	5.7	5.7	5.3	0.4	0.4	0.4	0.2	0.2	0.2
Sedatives	5.1	4.8	4.9	0.4	0.3	0.2	0.2^a	0.1	0.1

51020

**Table 2.5AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	24,371	24,844	25,503	7,472	7,559	7,460	3,086	3,123	3,019
Pain Relievers	16,237	16,824	17,273	5,917	6,121	5,903	2,303	2,416	2,187
OxyContin^®	1,161^b	1,804	1,938	--	--	741	--	--	177
Tranquilizers	10,051	10,159	10,551	2,390	2,498	2,399	829	818	810
Stimulants	11,703	11,273	11,211	1,659	1,399	1,563	652	633	604
Methamphetamine	7,401	7,363	6,985	859	778	889	343	398	300
Sedatives	5,653	5,590	5,499	490	323	317	196	99	103
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	21.5	21.6	21.9	6.6	6.6	6.4	2.7	2.7	2.6
Pain Relievers	14.3	14.6	14.8	5.2	5.3	5.1	2.0	2.1	1.9
OxyContin^®	1.0^b	1.6	1.7	--	--	0.6	--	--	0.2
Tranquilizers	8.8	8.8	9.1	2.1	2.2	2.1	0.7	0.7	0.7
Stimulants	10.3	9.8	9.6	1.5	1.2	1.3	0.6	0.6	0.5
Methamphetamine	6.5	6.4	6.0	0.8	0.7	0.8	0.3	0.3	0.3
Sedatives	5.0	4.9	4.7	0.4	0.3	0.3	0.2^a	0.1	0.1

51020

**Table 2.6AB Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Numbers in Thousands and Percentages, 2002-2004**
Drug	TIME PERIOD
	Lifetime			Past Year			Past Month
	2002	2003	2004	2002	2003	2004	2002	2003	2004
	Numbers in Thousands
*Low precision; no estimate reported. -- Not available. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Nonmedical Use of Psychotherapeutics¹	22,187	23,038	22,510	7,208	7,427	7,183	3,125	3,213	2,988
Pain Relievers	13,374^a	14,383	14,496	5,075	5,549	5,353	2,075	2,277	2,217
OxyContin^®	763^b	1,029	1,134	--	--	472	--	--	148
Tranquilizers	9,216	10,061	9,302	2,458	2,553	2,669	975	1,012	806
Stimulants	9,369	9,525	8,770	1,522	1,352	1,355	566	558	585
Methamphetamine	4,982	4,941	4,741	682	537	551	254	210	282
Sedatives	4,308	3,921	4,392	490	509	420	241	195	162
Drug	Percentages
Nonmedical Use of Psychotherapeutics¹	18.3	18.8	18.1	5.9	6.1	5.8	2.6	2.6	2.4
Pain Relievers	11.0	11.7	11.7	4.2	4.5	4.3	1.7	1.9	1.8
OxyContin^®	0.6^b	0.8	0.9	--	--	0.4	--	--	0.1
Tranquilizers	7.6	8.2	7.5	2.0	2.1	2.2	0.8	0.8	0.6
Stimulants	7.7	7.8	7.1	1.3	1.1	1.1	0.5	0.5	0.5
Methamphetamine	4.1	4.0	3.8	0.6	0.4	0.4	0.2	0.2	0.2
Sedatives	3.5	3.2	3.5	0.4	0.4	0.3	0.2	0.2	0.1

51020

**Table 2.7A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year, by Detailed Age Category: Numbers in Thousands, Annual Averages Based on 2002-2004**
Age Category	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14,769	11,306	4,989	2,950	1,432	850
12	122	101	14	18	3	9
13	215	180	25	42	11	19
14	323	274	61	73	24	20
15	437	358	104	126	46	28
16	546	454	160	148	46	34
17	623	518	198	165	57	25
18	715	610	214	171	68	26
19	680	553	224	191	76	17
20	641	520	227	170	56	19
21	616	498	228	172	81	25
22	565	444	204	140	62	23
23	525	430	197	126	70	21
24	474	388	180	99	58	17
25	372	284	141	77	46	14
26-29	1,531	1,176	553	257	150	72
30-34	1,407	1,038	493	269	180	71
35-39	1,374	982	470	201	139	91
40-44	1,268	907	446	226	123	92
45-49	1,115	779	384	166	106	97
50-54	517	371	208	58	14	55
55-59	273	183	119	16	14	30
60-64	218	125	83	8	4	17
65+	214	134	55	30	*	31

51020

**Table 2.7B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year, by Detailed Age Category: Percentages, Annual Averages Based on 2002-2004**
Age Category	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	6.2	4.8	2.1	1.2	0.6	0.4
12	3.0	2.5	0.4	0.4	0.1	0.2
13	5.0	4.2	0.6	1.0	0.3	0.4
14	7.5	6.4	1.4	1.7	0.5	0.5
15	10.5	8.6	2.5	3.0	1.1	0.7
16	13.3	11.0	3.9	3.6	1.1	0.8
17	15.4	12.8	4.9	4.1	1.4	0.6
18	15.8	13.5	4.7	3.8	1.5	0.6
19	17.1	13.9	5.7	4.8	1.9	0.4
20	16.0	13.0	5.7	4.2	1.4	0.5
21	15.3	12.4	5.7	4.3	2.0	0.6
22	14.2	11.2	5.1	3.5	1.6	0.6
23	13.4	11.0	5.0	3.2	1.8	0.5
24	12.7	10.4	4.8	2.7	1.5	0.5
25	10.6	8.1	4.0	2.2	1.3	0.4
26-29	10.1	7.8	3.7	1.7	1.0	0.5
30-34	7.1	5.2	2.5	1.4	0.9	0.4
35-39	6.5	4.6	2.2	0.9	0.7	0.4
40-44	5.7	4.0	2.0	1.0	0.5	0.4
45-49	5.2	3.6	1.8	0.8	0.5	0.5
50-54	2.7	1.9	1.1	0.3	0.1	0.3
55-59	1.8	1.2	0.8	0.1	0.1	0.2
60-64	1.8	1.0	0.7	0.1	0.0	0.1
65+	0.6	0.4	0.2	0.1	*	0.1

51020

Table 2.8A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14,769	11,306	4,989	2,950	1,432	850
AGE
12-17	2,266	1,884	562	571	187	134
18-25	4,587	3,726	1,616	1,147	516	160
26 or Older	7,917	5,696	2,811	1,232	729	555
GENDER
Male	7,497	5,980	2,429	1,540	842	377
Female	7,272	5,326	2,560	1,410	590	473
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12,883	9,807	4,547	2,693	1,280	790
White	11,151	8,395	4,167	2,424	1,141	711
Black or African American	1,079	931	168	107	33	48
American Indian or Alaska Native	109	75	44	32	22	6
Native Hawaiian or Other Pacific Islander	66	47	8	21	14	5
Asian	287	216	80	38	20	7
Two or More Races	192	143	80	71	49	14
Hispanic or Latino	1,886	1,499	443	257	151	59

51020

**Table 2.8B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	6.2	4.8	2.1	1.2	0.6	0.4
AGE
12-17	9.1	7.5	2.2	2.3	0.7	0.5
18-25	14.5	11.8	5.1	3.6	1.6	0.5
26 or Older	4.4	3.1	1.6	0.7	0.4	0.3
GENDER
Male	6.5	5.2	2.1	1.3	0.7	0.3
Female	5.9	4.3	2.1	1.1	0.5	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.2	4.7	2.2	1.3	0.6	0.4
White	6.7	5.1	2.5	1.5	0.7	0.4
Black or African American	3.9	3.4	0.6	0.4	0.1	0.2
American Indian or Alaska Native	8.1	5.6	3.3	2.4	1.7	0.4
Native Hawaiian or Other Pacific Islander	10.1	7.2	1.2	3.3	2.2	0.8
Asian	3.0	2.3	0.8	0.4	0.2	0.1
Two or More Races	7.5	5.6	3.1	2.8	1.9	0.5
Hispanic or Latino	6.3	5.0	1.5	0.9	0.5	0.2

51020

**Table 2.9A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	2,266	1,884	562	571	187	134
GENDER
Male	1,051	893	244	249	78	57
Female	1,214	991	318	323	110	77
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,923	1,598	483	509	155	117
White	1,580	1,300	439	456	138	92
Black or African American	229	206	15	24	4	16
American Indian or Alaska Native	27	22	8	8	6	2
Native Hawaiian or Other Pacific Islander	7	6	*	4	1	*
Asian	40	32	9	7	3	2
Two or More Races	39	33	11	10	3	3
Hispanic or Latino	342	286	79	62	32	17

51020

**Table 2.9B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	9.1	7.5	2.2	2.3	0.7	0.5
GENDER
Male	8.2	7.0	1.9	1.9	0.6	0.4
Female	9.9	8.1	2.6	2.6	0.9	0.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.2	7.6	2.3	2.4	0.7	0.6
White	10.2	8.4	2.8	2.9	0.9	0.6
Black or African American	6.2	5.5	0.4	0.6	0.1	0.4
American Indian or Alaska Native	15.2	12.2	4.6	4.5	3.6	1.3
Native Hawaiian or Other Pacific Islander	9.9	7.9	*	5.2	0.8	*
Asian	4.1	3.3	0.9	0.7	0.3	0.2
Two or More Races	9.6	8.1	2.6	2.4	0.6	0.7
Hispanic or Latino	8.4	7.0	1.9	1.5	0.8	0.4

51020

Table 2.10A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	4,587	3,726	1,616	1,147	516	160
GENDER
Male	2,481	2,084	854	616	290	82
Female	2,106	1,641	762	530	225	78
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,004	3,263	1,456	1,029	447	139
White	3,500	2,839	1,344	933	403	127
Black or African American	292	262	53	34	8	5
American Indian or Alaska Native	36	25	13	16	12	1
Native Hawaiian or Other Pacific Islander	17	14	2	4	3	0
Asian	87	69	18	20	6	3
Two or More Races	72	54	26	23	15	3
Hispanic or Latino	583	463	160	117	69	22
EDUCATION
< High School	1,097	920	385	239	154	33
High School Graduate	1,526	1,248	520	368	206	56
Some College	1,533	1,221	552	432	132	53
College Graduate	430	337	159	107	23	19
CURRENT EMPLOYMENT
Full-Time	2,056	1,699	736	446	222	66
Part-Time	1,200	971	398	318	105	45
Unemployed	486	388	197	145	92	19
Other¹	845	668	285	237	97	31

51020

**Table 2.10B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14.5	11.8	5.1	3.6	1.6	0.5
GENDER
Male	15.6	13.1	5.4	3.9	1.8	0.5
Female	13.3	10.4	4.8	3.4	1.4	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.4	12.5	5.6	4.0	1.7	0.5
White	17.8	14.5	6.8	4.8	2.1	0.6
Black or African American	6.9	6.2	1.2	0.8	0.2	0.1
American Indian or Alaska Native	18.9	13.1	7.0	8.7	6.5	0.6
Native Hawaiian or Other Pacific Islander	11.4	9.1	1.5	2.5	2.0	0.1
Asian	6.0	4.7	1.3	1.4	0.4	0.2
Two or More Races	19.3	14.5	7.0	6.1	3.9	0.8
Hispanic or Latino	10.4	8.2	2.8	2.1	1.2	0.4
EDUCATION
< High School	16.1	13.5	5.6	3.5	2.3	0.5
High School Graduate	14.0	11.5	4.8	3.4	1.9	0.5
Some College	15.3	12.2	5.5	4.3	1.3	0.5
College Graduate	10.8	8.5	4.0	2.7	0.6	0.5
CURRENT EMPLOYMENT
Full-Time	14.0	11.5	5.0	3.0	1.5	0.4
Part-Time	14.9	12.0	4.9	3.9	1.3	0.6
Unemployed	18.9	15.1	7.7	5.6	3.6	0.7
Other¹	13.5	10.6	4.5	3.8	1.5	0.5

51020

Table 2.11A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	7,917	5,696	2,811	1,232	729	555
GENDER
Male	3,965	3,003	1,331	675	474	237
Female	3,952	2,694	1,480	557	255	318
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6,956	4,946	2,607	1,155	678	534
White	6,071	4,257	2,384	1,035	600	492
Black or African American	557	463	101	49	21	27
American Indian or Alaska Native	46	29	22	8	4	2
Native Hawaiian or Other Pacific Islander	41	27	4	14	*	*
Asian	160	115	53	11	11	2
Two or More Races	81	56	43	38	32	8
Hispanic or Latino	962	750	204	77	50	21
EDUCATION
< High School	1,356	1,067	436	221	152	77
High School Graduate	2,499	1,802	876	453	287	163
Some College	2,201	1,600	768	365	221	151
College Graduate	1,860	1,227	731	193	69	164
CURRENT EMPLOYMENT
Full-Time	5,061	3,714	1,711	712	425	316
Part-Time	982	627	362	183	103	56
Unemployed	478	378	209	123	79	72
Other¹	1,397	978	528	215	121	111

51020

**Table 2.11B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	4.4	3.1	1.6	0.7	0.4	0.3
GENDER
Male	4.6	3.5	1.5	0.8	0.5	0.3
Female	4.2	2.8	1.6	0.6	0.3	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4.3	3.1	1.6	0.7	0.4	0.3
White	4.6	3.2	1.8	0.8	0.5	0.4
Black or African American	2.9	2.4	0.5	0.3	0.1	0.1
American Indian or Alaska Native	4.7	2.9	2.3	0.8	0.4	0.2
Native Hawaiian or Other Pacific Islander	9.8	6.4	1.0	3.3	*	*
Asian	2.2	1.6	0.7	0.1	0.1	0.0
Two or More Races	4.6	3.2	2.4	2.2	1.8	0.4
Hispanic or Latino	4.7	3.7	1.0	0.4	0.2	0.1
EDUCATION
< High School	4.5	3.5	1.4	0.7	0.5	0.3
High School Graduate	4.4	3.2	1.5	0.8	0.5	0.3
Some College	5.1	3.7	1.8	0.8	0.5	0.3
College Graduate	3.7	2.4	1.4	0.4	0.1	0.3
CURRENT EMPLOYMENT
Full-Time	4.9	3.6	1.7	0.7	0.4	0.3
Part-Time	5.0	3.2	1.8	0.9	0.5	0.3
Unemployed	9.4	7.4	4.1	2.4	1.6	1.4
Other¹	2.6	1.8	1.0	0.4	0.2	0.2

51128

Table 2.12A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	12,504	9,422	4,427	2,379	1,244	716
GENDER
Male	6,446	5,087	2,185	1,291	764	320
Female	6,058	4,335	2,243	1,087	480	396
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	10,960	8,209	4,064	2,184	1,125	673
White	9,571	7,096	3,728	1,968	1,003	619
Black or African American	849	726	153	83	29	31
American Indian or Alaska Native	82	54	36	24	16	3
Native Hawaiian or Other Pacific Islander	58	41	6	17	13	*
Asian	247	184	71	30	17	5
Two or More Races	152	110	69	61	46	11
Hispanic or Latino	1,544	1,213	364	194	119	43
EDUCATION
< High School	2,453	1,987	821	460	307	109
High School Graduate	4,026	3,050	1,396	821	492	219
Some College	3,735	2,821	1,320	797	354	204
College Graduate	2,290	1,564	890	300	92	184
CURRENT EMPLOYMENT
Full-Time	7,117	5,413	2,447	1,158	647	382
Part-Time	2,182	1,598	760	501	208	101
Unemployed	964	765	406	268	171	91
Other¹	2,242	1,646	814	451	218	142

51020

**Table 2.12B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Demographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Retired persons, disabled persons, homemakers, students, or other persons not in the labor force are included in the Other Employment category. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	5.9	4.4	2.1	1.1	0.6	0.3
GENDER
Male	6.3	5.0	2.1	1.3	0.7	0.3
Female	5.5	3.9	2.0	1.0	0.4	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5.9	4.4	2.2	1.2	0.6	0.4
White	6.4	4.7	2.5	1.3	0.7	0.4
Black or African American	3.6	3.1	0.6	0.4	0.1	0.1
American Indian or Alaska Native	7.0	4.6	3.0	2.1	1.4	0.3
Native Hawaiian or Other Pacific Islander	10.2	7.1	1.1	3.1	2.3	*
Asian	2.9	2.1	0.8	0.4	0.2	0.1
Two or More Races	7.1	5.1	3.2	2.8	2.2	0.5
Hispanic or Latino	6.0	4.7	1.4	0.8	0.5	0.2
EDUCATION
< High School	6.6	5.3	2.2	1.2	0.8	0.3
High School Graduate	5.9	4.5	2.1	1.2	0.7	0.3
Some College	7.0	5.3	2.5	1.5	0.7	0.4
College Graduate	4.2	2.9	1.6	0.6	0.2	0.3
CURRENT EMPLOYMENT
Full-Time	6.1	4.6	2.1	1.0	0.6	0.3
Part-Time	7.8	5.7	2.7	1.8	0.7	0.4
Unemployed	12.5	10.0	5.3	3.5	2.2	1.2
Other¹	3.8	2.8	1.4	0.8	0.4	0.2

51021

Table 2.13A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14,769	11,306	4,989	2,950	1,432	850
GEOGRAPHIC DIVISION
Northeast	2,366	1,823	831	410	58	184
New England	789	557	275	172	16	89
Middle Atlantic	1,578	1,266	556	238	41	96
Midwest	3,123	2,416	956	676	300	168
East North Central	2,238	1,791	712	404	136	101
West North Central	886	624	244	272	165	67
South	5,363	4,100	2,178	962	426	300
South Atlantic	2,703	2,098	1,111	388	145	164
East South Central	967	737	464	192	94	58
West South Central	1,693	1,264	603	381	187	78
West	3,916	2,967	1,024	903	648	197
Mountain	1,193	927	343	273	207	56
Pacific	2,723	2,040	682	629	441	141
COUNTY TYPE
Large Metro	7,581	5,828	2,571	1,351	600	419
Small Metro	4,844	3,670	1,668	1,033	493	298
250K – 1 Mil. Pop.	3,130	2,356	1,042	630	308	161
< 250K Pop.	1,714	1,314	626	403	185	137
Nonmetro	2,345	1,808	751	566	338	133
Urbanized	1,060	848	333	247	144	42
Less Urbanized	1,092	818	349	266	167	82
Completely Rural	193	142	69	53	27	9

51021

**Table 2.13B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	6.2	4.8	2.1	1.2	0.6	0.4
GEOGRAPHIC DIVISION
Northeast	5.2	4.0	1.8	0.9	0.1	0.4
New England	6.6	4.7	2.3	1.4	0.1	0.7
Middle Atlantic	4.7	3.8	1.7	0.7	0.1	0.3
Midwest	5.8	4.5	1.8	1.3	0.6	0.3
East North Central	5.9	4.8	1.9	1.1	0.4	0.3
West North Central	5.5	3.9	1.5	1.7	1.0	0.4
South	6.3	4.8	2.6	1.1	0.5	0.4
South Atlantic	6.1	4.7	2.5	0.9	0.3	0.4
East South Central	6.8	5.2	3.3	1.3	0.7	0.4
West South Central	6.5	4.8	2.3	1.5	0.7	0.3
West	7.3	5.5	1.9	1.7	1.2	0.4
Mountain	7.6	5.9	2.2	1.7	1.3	0.4
Pacific	7.1	5.3	1.8	1.6	1.2	0.4
COUNTY TYPE
Large Metro	6.0	4.6	2.0	1.1	0.5	0.3
Small Metro	6.8	5.2	2.4	1.5	0.7	0.4
250K – 1 Mil. Pop.	6.7	5.1	2.2	1.4	0.7	0.3
< 250K Pop.	7.1	5.4	2.6	1.7	0.8	0.6
Nonmetro	5.8	4.5	1.9	1.4	0.8	0.3
Urbanized	6.3	5.0	2.0	1.5	0.9	0.2
Less Urbanized	5.6	4.2	1.8	1.4	0.9	0.4
Completely Rural	4.8	3.5	1.7	1.3	0.7	0.2

51021

**Table 2.14A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	2,266	1,884	562	571	187	134
GEOGRAPHIC DIVISION
Northeast	350	294	74	89	13	23
New England	108	89	25	32	5	8
Middle Atlantic	241	205	48	57	8	15
Midwest	508	416	101	147	40	28
East North Central	364	309	71	99	23	20
West North Central	144	108	30	49	17	9
South	834	682	271	202	69	54
South Atlantic	408	332	129	94	33	26
East South Central	155	129	53	35	11	10
West South Central	271	222	90	74	26	18
West	574	491	116	132	64	28
Mountain	171	143	36	47	21	8
Pacific	404	348	80	86	43	20
COUNTY TYPE
Large Metro	1,102	920	260	272	78	67
Small Metro	728	600	198	180	67	46
250K – 1 Mil. Pop.	480	389	130	116	40	32
< 250K Pop.	248	211	68	65	27	13
Nonmetro	435	364	103	119	42	22
Urbanized	185	158	42	44	15	7
Less Urbanized	213	175	52	62	24	12
Completely Rural	37	31	9	13	3	2

51021

**Table 2.14B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	9.1	7.5	2.2	2.3	0.7	0.5
GEOGRAPHIC DIVISION
Northeast	7.8	6.5	1.6	2.0	0.3	0.5
New England	9.3	7.7	2.2	2.8	0.4	0.7
Middle Atlantic	7.3	6.2	1.4	1.7	0.2	0.5
Midwest	8.9	7.3	1.8	2.6	0.7	0.5
East North Central	9.1	7.7	1.8	2.5	0.6	0.5
West North Central	8.5	6.4	1.8	2.9	1.0	0.5
South	9.4	7.7	3.0	2.3	0.8	0.6
South Atlantic	9.1	7.4	2.9	2.1	0.7	0.6
East South Central	10.7	8.9	3.6	2.4	0.8	0.7
West South Central	9.1	7.5	3.0	2.5	0.9	0.6
West	9.7	8.3	2.0	2.2	1.1	0.5
Mountain	9.9	8.3	2.1	2.7	1.2	0.5
Pacific	9.7	8.3	1.9	2.1	1.0	0.5
COUNTY TYPE
Large Metro	8.3	6.9	2.0	2.0	0.6	0.5
Small Metro	9.8	8.1	2.7	2.4	0.9	0.6
250K – 1 Mil. Pop.	9.6	7.8	2.6	2.3	0.8	0.6
< 250K Pop.	10.2	8.7	2.8	2.7	1.1	0.6
Nonmetro	10.2	8.5	2.4	2.8	1.0	0.5
Urbanized	10.5	9.0	2.4	2.5	0.8	0.4
Less Urbanized	10.2	8.4	2.5	3.0	1.2	0.6
Completely Rural	8.7	7.1	2.0	3.1	0.8	0.5

51021

**Table 2.15A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	4,587	3,726	1,616	1,147	516	160
GEOGRAPHIC DIVISION
Northeast	800	655	255	214	28	29
New England	262	214	83	89	10	8
Middle Atlantic	538	441	172	124	19	22
Midwest	1,035	851	324	264	118	33
East North Central	747	636	238	162	54	23
West North Central	288	215	86	103	64	10
South	1,703	1,369	749	391	166	63
South Atlantic	792	653	324	162	50	31
East South Central	314	255	169	69	34	11
West South Central	598	461	255	160	82	22
West	1,048	851	288	278	203	35
Mountain	357	287	113	90	65	17
Pacific	691	564	175	188	138	18
COUNTY TYPE
Large Metro	2,210	1,801	763	512	218	84
Small Metro	1,617	1,305	586	430	178	54
250K – 1 Mil. Pop.	1,009	808	352	254	104	33
< 250K Pop.	608	496	235	176	74	21
Nonmetro	759	620	267	205	119	23
Urbanized	367	306	130	92	46	11
Less Urbanized	339	274	119	99	65	11
Completely Rural	54	41	18	14	8	1

51021

**Table 2.15B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	14.5	11.8	5.1	3.6	1.6	0.5
GEOGRAPHIC DIVISION
Northeast	14.3	11.7	4.6	3.8	0.5	0.5
New England	17.9	14.6	5.7	6.1	0.7	0.5
Middle Atlantic	13.0	10.6	4.2	3.0	0.5	0.5
Midwest	14.1	11.6	4.4	3.6	1.6	0.5
East North Central	14.8	12.6	4.7	3.2	1.1	0.5
West North Central	12.7	9.5	3.8	4.5	2.8	0.4
South	15.1	12.1	6.6	3.5	1.5	0.6
South Atlantic	14.2	11.7	5.8	2.9	0.9	0.6
East South Central	16.3	13.2	8.8	3.6	1.8	0.5
West South Central	15.7	12.1	6.7	4.2	2.2	0.6
West	14.1	11.5	3.9	3.8	2.7	0.5
Mountain	16.0	12.9	5.1	4.0	2.9	0.7
Pacific	13.3	10.9	3.4	3.6	2.7	0.3
COUNTY TYPE
Large Metro	13.5	11.0	4.7	3.1	1.3	0.5
Small Metro	15.7	12.6	5.7	4.2	1.7	0.5
250K – 1 Mil. Pop.	15.2	12.1	5.3	3.8	1.6	0.5
< 250K Pop.	16.6	13.5	6.4	4.8	2.0	0.6
Nonmetro	15.4	12.5	5.4	4.1	2.4	0.5
Urbanized	15.9	13.3	5.6	4.0	2.0	0.5
Less Urbanized	15.0	12.1	5.3	4.4	2.9	0.5
Completely Rural	14.0	10.6	4.8	3.7	2.2	0.3

51021

Table 2.16A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, Annual Averages Based on 2002-2004
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	7,917	5,696	2,811	1,232	729	555
GEOGRAPHIC DIVISION
Northeast	1,217	874	502	107	16	132
New England	418	254	167	50	2	73
Middle Atlantic	798	620	335	57	14	59
Midwest	1,581	1,148	531	264	142	107
East North Central	1,127	847	404	143	59	58
West North Central	454	302	127	121	83	49
South	2,826	2,049	1,158	369	191	182
South Atlantic	1,503	1,114	658	133	63	107
East South Central	499	354	242	89	49	37
West South Central	824	581	258	147	79	38
West	2,294	1,625	620	492	380	134
Mountain	666	497	193	137	120	31
Pacific	1,628	1,128	427	355	260	103
COUNTY TYPE
Large Metro	4,268	3,107	1,548	567	304	268
Small Metro	2,498	1,765	883	423	248	198
250K – 1 Mil. Pop.	1,640	1,159	560	261	164	96
< 250K Pop.	858	606	323	162	84	102
Nonmetro	1,151	824	380	242	177	89
Urbanized	508	384	161	111	83	24
Less Urbanized	541	369	178	105	78	59
Completely Rural	102	71	42	26	15	6

51021

**Table 2.16B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, Annual Averages Based on 2002-2004**
Geographic Characteristic	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	4.4	3.1	1.6	0.7	0.4	0.3
GEOGRAPHIC DIVISION
Northeast	3.5	2.5	1.4	0.3	0.0	0.4
New England	4.5	2.7	1.8	0.5	0.0	0.8
Middle Atlantic	3.1	2.4	1.3	0.2	0.1	0.2
Midwest	3.9	2.8	1.3	0.6	0.3	0.3
East North Central	3.9	3.0	1.4	0.5	0.2	0.2
West North Central	3.7	2.5	1.0	1.0	0.7	0.4
South	4.4	3.2	1.8	0.6	0.3	0.3
South Atlantic	4.4	3.2	1.9	0.4	0.2	0.3
East South Central	4.6	3.3	2.2	0.8	0.4	0.3
West South Central	4.2	3.0	1.3	0.8	0.4	0.2
West	5.7	4.0	1.5	1.2	0.9	0.3
Mountain	5.7	4.3	1.7	1.2	1.0	0.3
Pacific	5.7	3.9	1.5	1.2	0.9	0.4
COUNTY TYPE
Large Metro	4.4	3.2	1.6	0.6	0.3	0.3
Small Metro	4.7	3.3	1.7	0.8	0.5	0.4
250K – 1 Mil. Pop.	4.7	3.3	1.6	0.7	0.5	0.3
< 250K Pop.	4.7	3.3	1.8	0.9	0.5	0.6
Nonmetro	3.7	2.7	1.2	0.8	0.6	0.3
Urbanized	4.0	3.0	1.3	0.9	0.7	0.2
Less Urbanized	3.6	2.5	1.2	0.7	0.5	0.4
Completely Rural	3.2	2.2	1.3	0.8	0.5	0.2

51031

Table 2.17A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Lifetime Users Aged 18 or Older, by Drug Type and Age at First Use: Numbers in Thousands, Annual Averages Based on 2002-2004
Age at First Use	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
	Past Year Use among Lifetime Users Aged 18 or Older
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	12,504	9,422	4,427	2,379	1,244	716
Under 16 Years	2,232	1,388	440	372	150	109
16 Years or Older	10,271	8,034	3,988	2,006	1,095	606
16 to 20 Years	5,423	3,882	1,697	1,148	574	235
21 to 25 Years	2,221	1,807	901	438	268	92
26 Years or Older	2,627	2,345	1,390	421	253	279
Age at First Use	Past Year Use among Lifetime Users Aged 18 to 25
TOTAL	4,587	3,726	1,616	1,147	516	160
Under 16 Years	1,028	683	232	206	86	36
16 Years or Older	3,558	3,042	1,385	941	430	125
16 to 20 Years	2,966	2,483	1,057	796	348	91
21 to 25 Years	592	559	328	145	82	34
Age at First Use	Past Year Use among Lifetime Users Aged 26 or Older
TOTAL	7,917	5,696	2,811	1,232	729	555
Under 16 Years	1,204	704	208	166	64	73
16 Years or Older	6,713	4,992	2,603	1,066	665	482
16 to 20 Years	2,457	1,398	640	353	226	144
21 to 25 Years	1,629	1,248	573	293	186	59
26 Years or Older	2,627	2,345	1,390	421	253	279

51031

Table 2.17B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Lifetime Users Aged 18 or Older, by Drug Type and Age at First Use: Percentages, Annual Averages Based on 2002-2004
Age at First Use	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
	Past Year Use among Lifetime Users Aged 18 or Older
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
TOTAL	28.3	33.6	23.4	12.1	10.5	7.5
Under 16 Years	33.4	38.0	22.6	12.4	9.1	7.6
16 Years or Older	27.4	32.9	23.5	12.1	10.8	7.5
16 to 20 Years	27.8	34.9	23.6	11.4	9.2	4.9
21 to 25 Years	24.7	29.5	20.0	10.8	10.5	5.1
26 Years or Older	29.5	32.7	26.2	16.9	18.6	19.3
Age at First Use	Past Year Use among Lifetime Users Aged 18 to 25
TOTAL	50.6	50.4	43.0	33.8	30.4	26.2
Under 16 Years	51.3	49.8	39.8	26.0	23.0	26.2
16 Years or Older	50.4	50.5	43.5	36.1	32.4	26.2
16 to 20 Years	49.3	49.1	40.7	34.7	30.1	22.8
21 to 25 Years	56.8	57.7	55.8	47.0	48.9	43.7
Age at First Use	Past Year Use among Lifetime Users Aged 26 or Older
TOTAL	22.6	27.6	18.5	7.6	7.2	6.2
Under 16 Years	25.7	30.9	15.3	7.5	5.1	5.6
16 Years or Older	22.1	27.2	18.8	7.6	7.5	6.3
16 to 20 Years	18.2	23.1	13.9	4.5	4.4	3.2
21 to 25 Years	20.5	24.2	14.6	7.9	7.8	3.4
26 Years or Older	29.5	32.7	26.2	16.9	18.6	19.3

51024

Table 2.18A Number of Days of Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Past Year Users of the Drug Type, by Age Category: Numbers in Thousands, Annual Averages Based on 2002-2004
Number of Days Used in Past Year	PRESCRIPTION DRUG TYPE
	Pain Relievers	Tranquilizers	Stimulants		Sedatives
	Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
	Past Year Nonmedical Users Aged 12 or Older
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
1-11 Days	5,741	2,637	1,257	550	399
12-49 Days	2,744	1,201	657	306	239
50-99 Days	1,224	549	331	176	85
100-299 Days	1,404	550	597	336	114
300 or More Days	193	53	108	64	12
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 12 to 17
1-11 Days	899	295	276	91	61
12-49 Days	489	139	134	46	34
50-99 Days	232	58	58	17	22
100-299 Days	235	67	90	29	14
300 or More Days	28	3	12	3	3
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 18 to 25
1-11 Days	1,911	862	518	203	82
12-49 Days	951	393	281	121	38
50-99 Days	396	176	125	62	23
100-299 Days	420	172	200	118	16
300 or More Days	48	13	23	12	2
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 26 or Older
1-11 Days	2,931	1,479	463	256	256
12-49 Days	1,304	669	242	138	168
50-99 Days	596	315	148	97	40
100-299 Days	749	311	306	190	84
300 or More Days	116	37	72	49	8

51024

Table 2.18B Number of Days of Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Past Year Users of the Drug Type, by Age Category: Percentage Distributions, Annual Averages Based on 2002-2004
Number of Days Used in Past Year	PRESCRIPTION DRUG TYPE
	Pain Relievers	Tranquilizers	Stimulants		Sedatives
	Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetamine	Sedatives
	Past Year Nonmedical Users Aged 12 or Older
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
1-11 Days	50.8	52.8	42.6	38.4	46.9
12-49 Days	24.3	24.1	22.3	21.4	28.2
50-99 Days	10.8	11.0	11.2	12.3	10.0
100-299 Days	12.4	11.0	20.2	23.5	13.4
300 or More Days	1.7	1.1	3.7	4.5	1.5
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 12 to 17
1-11 Days	47.7	52.5	48.3	48.8	45.4
12-49 Days	25.9	24.7	23.5	24.8	25.5
50-99 Days	12.3	10.3	10.1	9.3	16.6
100-299 Days	12.5	11.9	15.8	15.3	10.4
300 or More Days	1.5	0.5	2.2	1.8	2.1
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 18 to 25
1-11 Days	51.3	53.3	45.2	39.3	50.8
12-49 Days	25.5	24.3	24.5	23.6	23.6
50-99 Days	10.6	10.9	10.9	12.0	14.4
100-299 Days	11.3	10.6	17.5	22.8	10.2
300 or More Days	1.3	0.8	2.0	2.3	1.0
Number of Days Used in Past Year	Past Year Nonmedical Users Aged 26 or Older
1-11 Days	51.5	52.6	37.6	35.2	46.1
12-49 Days	22.9	23.8	19.6	18.9	30.2
50-99 Days	10.5	11.2	12.0	13.3	7.2
100-299 Days	13.2	11.1	24.9	26.0	15.1
300 or More Days	2.0	1.3	5.9	6.7	1.4

51024

Table 2.19A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 22, by Gender and College Enrollment Status: Numbers in Thousands, Annual Averages Based on 2002-2004
Gender and College Enrollment Status	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetmaine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Estimates include those with unknown enrollment status. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ALL PERSONS AGED 18 TO 22¹	3,216	2,625	1,097	844	343	109
Enrolled as Undergraduate	1,374	1,105	434	403	82	43
Full Time	1,154	918	355	356	62	37
Part Time	219	188	79	48	21	6
Not Enrolled as Undergraduate	1,552	1,268	583	378	237	59
MALES AGED 18 TO 22¹	1,744	1,475	580	435	186	57
Enrolled as Undergraduate	671	559	205	193	39	18
Full Time	568	470	168	171	33	16
Part Time	102	89	36	22	7	2
Not Enrolled as Undergraduate	891	756	326	204	134	34
FEMALES AGED 18 TO 22¹	1,472	1,150	517	409	157	52
Enrolled as Undergraduate	703	546	230	210	43	25
Full Time	586	447	187	184	29	21
Part Time	117	99	43	26	14	4
Not Enrolled as Undergraduate	661	512	257	174	103	24

51024

Table 2.19B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Persons Aged 18 to 22, by Gender and College Enrollment Status: Percentages, Annual Averages Based on 2002-2004
Gender and College Enrollment Status	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetmaine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Estimates include those with unknown enrollment status. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ALL PERSONS AGED 18 TO 22¹	15.7	12.8	5.4	4.1	1.7	0.5
Enrolled as Undergraduate	14.8	11.9	4.7	4.3	0.9	0.5
Full Time	14.6	11.6	4.5	4.5	0.8	0.5
Part Time	15.7	13.4	5.7	3.4	1.5	0.4
Not Enrolled as Undergraduate	17.0	13.9	6.4	4.1	2.6	0.6
MALES AGED 18 TO 22¹	16.8	14.2	5.6	4.2	1.8	0.6
Enrolled as Undergraduate	15.6	13.0	4.7	4.5	0.9	0.4
Full Time	15.5	12.8	4.6	4.7	0.9	0.4
Part Time	15.8	13.8	5.6	3.4	1.0	0.3
Not Enrolled as Undergraduate	18.2	15.5	6.7	4.2	2.7	0.7
FEMALES AGED 18 TO 22¹	14.6	11.4	5.1	4.1	1.6	0.5
Enrolled as Undergraduate	14.2	11.0	4.6	4.2	0.9	0.5
Full Time	13.9	10.6	4.4	4.4	0.7	0.5
Part Time	15.6	13.1	5.8	3.4	1.9	0.5
Not Enrolled as Undergraduate	15.5	12.0	6.0	4.1	2.4	0.6

51024

Table 2.20A Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Females Aged 15 to 44, by Age Group and Pregnancy Status: Numbers in Thousands, Annual Averages Based on 2002-2004
Age and Pregnancy Status	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetmaine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Estimates include those with unknown pregnancy status. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ALL FEMALES AGED 15 TO 44¹	5,653	4,226	2,024	1,231	529	304
Pregnant	148	109	49	32	19	7
Not Pregnant	5,481	4,097	1,966	1,191	507	296
FEMALES AGED 15 TO 17¹	838	676	256	246	86	47
Pregnant	17	14	3	6	3	2
Not Pregnant	815	657	252	239	83	45
FEMALES AGED 18 TO 25¹	2,106	1,641	762	530	225	78
Pregnant	89	67	31	19	16	4
Not Pregnant	1,999	1,559	723	505	207	73
FEMALES AGED 26 TO 44¹	2,709	1,909	1,006	454	218	179
Pregnant	42	28	15	7	*	1
Not Pregnant	2,667	1,881	990	447	218	178

51024

**Table 2.20B Nonmedical Use of Prescription-Type Psychotherapeutics in the Past Year among Females Aged 15 to 44, by Age Group and Pregnancy Status: Percentages, Annual Averages Based on 2002-2004**
Age and Pregnancy Status	Any Prescription- Type Psycho- therapeutic Drug	PRESCRIPTION DRUG TYPE
		Pain Relievers	Tranquilizers	Stimulants		Sedatives
		Pain Relievers	Tranquilizers	Any Stimulant	Metham- phetmaine	Sedatives
*Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives; does not include over-the-counter drugs. ¹ Estimates include those with unknown pregnancy status. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ALL FEMALES AGED 15 TO 44¹	9.1	6.8	3.3	2.0	0.9	0.5
Pregnant	6.0	4.4	2.0	1.3	0.8	0.3
Not Pregnant	9.3	6.9	3.3	2.0	0.9	0.5
FEMALES AGED 15 TO 17¹	13.9	11.2	4.2	4.1	1.4	0.8
Pregnant	18.2	15.0	3.3	6.4	3.2	1.7
Not Pregnant	13.8	11.1	4.3	4.0	1.4	0.8
FEMALES AGED 18 TO 25¹	13.3	10.4	4.8	3.4	1.4	0.5
Pregnant	9.6	7.3	3.3	2.1	1.7	0.5
Not Pregnant	13.5	10.6	4.9	3.4	1.4	0.5
FEMALES AGED 26 TO 44¹	6.8	4.8	2.5	1.1	0.5	0.4
Pregnant	2.9	1.9	1.0	0.5	*	0.1
Not Pregnant	7.0	4.9	2.6	1.2	0.6	0.5

51020

**Table 3.1A Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Numbers in Thousands, 2002-2004**
Pain Reliever	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	18,912	19,672	19,514	1,508	1,458	1,504	3,800^b	4,020	4,202	13,603	14,193	13,808
Percocet^®, Percodan^®, or Tylox^®	9,659^b	10,811	10,950	407^b	473	529	2,285^b	2,471^b	2,796	6,967	7,867	7,626
Vicodin^®, Lortab^®, or Lorcet^®	13,093^b	15,717	16,707	1,116^a	1,129^a	1,274	4,126^b	4,773^b	5,309	7,852^b	9,815	10,124
Codeine	6,897	6,985	6,693	513	526	523	1,878	2,074	2,062	4,506	4,385	4,108
Demerol^®	2,917^a	2,986^b	2,461	116	109	126	657	686	624	2,144^a	2,191^a	1,711
Dilaudid^®	1,116	914	859	7	13	17	101	80	97	1,008	821	745
Fioricet^®	445	466	454	13	17	20	64	49	65	368	401	369
Fiorinal^®	579	525	372	24	18	11	40	43	33	515	465	327
Hydrocodone	4,529^b	5,716	5,949	333^b	410	425	1,540^b	2,088	2,161	2,656^b	3,218	3,363
Methadone	928^b	1,159	1,306	116	109	123	306^b	396	456	506	655	727
Morphine	2,073	2,060	2,068	256	215	218	648^b	737	818	1,170	1,107	1,031
OxyContin^®	1,924^b	2,832	3,072	224^b	254	305	820^b	1,145^b	1,376	881^b	1,433	1,392
Phenaphen^® with Codeine	873^a	857^b	586	69	67^a	40	194	236	177	610^a	554	369
Propoxyphene	282	290	390	31	33	22	45^b	68	101	206	189	267
SK-65^®	42	48	37	13	16	9	10	14	15	19	18	13
Stadol^®	133	157	154	6	5	4	23^a	16^b	49	103	136	101
Talacen^®	55	43	116	14	7	10	13	13	25	28	23	81
Talwin^®	643^b	425	302	10	6	17	20	22	19	613^b	397	267
Talwin^® NX	105	53	100	10	8	8	9	12	15	86	33	77
Tramadol	52^b	186^a	328	11	14	20	20^b	68	99	21^b	103	209
Ultram^®	962	1,105	1,113	98^b	66	51	300	330	318	564	709	744
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	20,653	21,428	21,066	1,696	1,693	1,702	4,337^a	4,611	4,692	14,620	15,124	14,672
Oxycodone Products^1,3	10,151^b	11,538	11,921	523^b	605	693	2,551^b	2,831^b	3,237	7,076^a	8,102	7,991
Hydrocodone Products^1,4	13,952^b	16,808	17,734	1,222^b	1,260^a	1,407	4,385^b	5,157^a	5,595	8,345^b	10,391	10,732
Tramadol Products^1,5	994^a	1,221	1,280	102	76	67	313	375	372	579^a	770	840

51020

**Table 3.1B Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Percentages, 2002-2004**
Pain Reliever	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	8.0	8.3	8.1	6.1	5.8	6.0	12.2	12.7	13.1	7.6	7.8	7.5
Percocet^®, Percodan^®, or Tylox^®	4.1^a	4.5	4.6	1.6^b	1.9	2.1	7.4^b	7.8^a	8.7	3.9	4.3	4.2
Vicodin^®, Lortab^®, or Lorcet^®	5.6^b	6.6	6.9	4.5^a	4.5^a	5.1	13.3^b	15.0^b	16.5	4.4^b	5.4	5.5
Codeine	2.9	2.9	2.8	2.1	2.1	2.1	6.1	6.5	6.4	2.5	2.4	2.2
Demerol^®	1.2^a	1.3^b	1.0	0.5	0.4	0.5	2.1	2.2	1.9	1.2^a	1.2^b	0.9
Dilaudid^®	0.5	0.4	0.4	0.0	0.1	0.1	0.3	0.3	0.3	0.6	0.5	0.4
Fioricet^®	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2
Fiorinal^®	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.3	0.2
Hydrocodone	1.9^b	2.4	2.5	1.3^a	1.6	1.7	5.0^b	6.6	6.7	1.5^b	1.8	1.8
Methadone	0.4^b	0.5	0.5	0.5	0.4	0.5	1.0^b	1.2	1.4	0.3	0.4	0.4
Morphine	0.9	0.9	0.9	1.0	0.9	0.9	2.1^a	2.3	2.5	0.7	0.6	0.6
OxyContin^®	0.8^b	1.2	1.3	0.9^a	1.0	1.2	2.6^b	3.6^b	4.3	0.5^b	0.8	0.8
Phenaphen^® with Codeine	0.4^a	0.4^b	0.2	0.3^a	0.3^a	0.2	0.6	0.7	0.6	0.3^a	0.3^a	0.2
Propoxyphene	0.1	0.1	0.2	0.1	0.1	0.1	0.1^b	0.2	0.3	0.1	0.1	0.1
SK-65^®	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Stadol^®	0.1	0.1	0.1	0.0	0.0	0.0	0.1^a	0.1^b	0.2	0.1	0.1	0.1
Talacen^®	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
Talwin^®	0.3^b	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.3^b	0.2	0.1
Talwin^® NX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tramadol	0.0^b	0.1^a	0.1	0.0	0.1	0.1	0.1^b	0.2	0.3	0.0^b	0.1	0.1
Ultram^®	0.4	0.5	0.5	0.4^b	0.3	0.2	1.0	1.0	1.0	0.3	0.4	0.4
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	8.8	9.0	8.8	6.9	6.8	6.7	14.0	14.5	14.6	8.2	8.4	8.0
Oxycodone Products^1,3	4.3^b	4.9	5.0	2.1^b	2.4	2.7	8.2^b	8.9^b	10.1	3.9	4.5	4.4
Hydrocodone Products^1,4	5.9^b	7.1	7.4	4.9^a	5.0	5.6	14.1^b	16.3^a	17.4	4.7^b	5.7	5.9
Tramadol Products^1,5	0.4^a	0.5	0.5	0.4^a	0.3	0.3	1.0	1.2	1.2	0.3^a	0.4	0.5

51020

**Table 3.2A Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Numbers in Thousands, 2002-2004**
Tranquilizer	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Klonopin^® or Clonazepam	2,374	2,851	2,746	180	160	164	724^b	964	1,048	1,470	1,727	1,533
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	8,208^b	9,500	9,369	429	437	449	2,091^b	2,379	2,495	5,688	6,684	6,425
Valium^® or Diazepam	14,386	14,671	14,607	427	424	380	2,312	2,473	2,434	11,648	11,773	11,794
Atarax^®	371^a	292	186	26	17	22	45	42	42	301^a	233	122
BuSpar^®	693	587	702	51	53	42	220	205	260	421	329	401
Equanil^®	75	128	78	14	13	10	12	14	21	49	101	47
Flexeril^®	1,781	1,994	1,968	47	49	34	295^b	377	461	1,439	1,569	1,473
Librium^®	1,454^a	1,121	981	17	20	29	79	84	61	1,358^a	1,017	891
Limbitrol^®	115	41^a	96	9	7	14	32	11	24	73	23	58
Meprobamate	161	170	129	9	12	17	21	11	13	131	148	98
Miltown^®	169	98	73	12	8	14	6	8	6	151	82	52
Rohypnol^®	375	408	346	40	46	24	160	189	140	175	173	181
Serax^®	215	170	114	17	9	11	29	17	31	169	144	72
Soma^®	2,276	2,572	2,616	142	152	138	729^b	793^b	975	1,405	1,626	1,503
Tranxene^®	214	189	143	10	13	10	16	23	31	188	153	103
Vistaril^®	356	258	275	21	11	20	64	35	54	271	212	201
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	18,132	18,930	18,643	729	732	704	3,223^b	3,645	3,602	14,180	14,553	14,337
Meprobamate Products^1,3	388	307	246	33	27	34	39	27	39	316	253	173
Muscle Relaxants^1,4	3,360^a	3,718	3,907	170	182	160	866^b	998^b	1,227	2,325	2,538	2,520

51020

**Table 3.2B Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Percentages, 2002-2004**
Tranquilizer	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Klonopin^® or Clonazepam	1.0	1.2	1.1	0.7	0.6	0.7	2.3^b	3.0	3.3	0.8	1.0	0.8
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	3.5^a	4.0	3.9	1.7	1.7	1.8	6.7^b	7.5	7.7	3.2	3.7	3.5
Valium^® or Diazepam	6.1	6.2	6.1	1.7	1.7	1.5	7.5	7.8	7.6	6.5	6.5	6.4
Atarax^®	0.2^a	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2^a	0.1	0.1
BuSpar^®	0.3	0.2	0.3	0.2	0.2	0.2	0.7	0.6	0.8	0.2	0.2	0.2
Equanil^®	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
Flexeril^®	0.8	0.8	0.8	0.2	0.2	0.1	0.9^b	1.2	1.4	0.8	0.9	0.8
Librium^®	0.6^a	0.5	0.4	0.1	0.1	0.1	0.3	0.3	0.2	0.8^a	0.6	0.5
Limbitrol^®	0.0	0.0^a	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0
Meprobamate	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1
Miltown^®	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0
Rohypnol^®	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.6	0.4	0.1	0.1	0.1
Serax^®	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0
Soma^®	1.0	1.1	1.1	0.6	0.6	0.5	2.3^b	2.5^a	3.0	0.8	0.9	0.8
Tranxene^®	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1
Vistaril^®	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.1
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	7.7	8.0	7.8	2.9	2.9	2.8	10.4	11.5	11.2	7.9	8.0	7.8
Meprobamate Products^1,3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1
Muscle Relaxants^1,4	1.4	1.6	1.6	0.7	0.7	0.6	2.8^b	3.1^b	3.8	1.3	1.4	1.4

51020

**Table 3.3A Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Numbers in Thousands, 2002-2004**
Stimulant	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	12,383	12,303	11,726	366	328	299	1,756	1,650	1,688	10,261	10,325	9,739
Prescription Diet Pills²	8,980	8,671	8,104	267	251	236	692	743	689	8,021	7,677	7,179
Ritalin^® or Methylphenidate	4,528	4,168	4,182	587^b	547^a	445	1,662	1,806	1,729	2,280	1,816	2,008
Cylert^®	196	198	232	18	23	26	39	36	32	139	140	173
Dexedrine^®	3,274^b	2,553	2,580	70	69	62	318	291	318	2,887^b	2,193	2,200
Dextroamphetamine	553	498	675	22	31	29	78	80	83	453	387	563
Didrex^®	177	196	184	21	19	13	31	25	33	124	152	138
Eskatrol^®	302	89^a	289	10	4	15	15	4	13	276	81^a	261
Ionamin^®	491	583	459	19	26	12	28	23	13	445	535	433
Mazanor^®	65	30	65	16	10	13	3	8	8	45	13	44
Obedrin-LA^®	79	18	*	6	13	*	6	5	*	68	*	*
Plegine^®	68	45	25	12	5	13	8	2	3	48	37	9
Preludin^®	856^a	705	529	10	13	13	35	52^a	23	811^a	640	493
Sanorex^®	137	105	106	12	20	23	23	17	33	102	68	50
Tenuate^®	275	146	221	10	13	10	10	17	14	255	116	196
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine and Phentermine Products^3,4	10,589^a	10,080	9,509	367	385	357	1,069	1,117	1,177	9,153^a	8,578	7,974
Mazindol Products^3,5	187	127	156	24	26	32	25	21	34	138	80	90

51020

**Table 3.3B Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Percentages, 2002-2004**
Stimulant	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	5.3	5.2	4.9	1.5^a	1.3	1.2	5.7	5.2	5.2	5.7	5.7	5.3
Prescription Diet Pills²	3.8^a	3.6	3.4	1.1	1.0	0.9	2.2	2.3	2.1	4.5^a	4.2	3.9
Ritalin^® or Methylphenidate	1.9	1.8	1.7	2.4^b	2.2^b	1.8	5.4	5.7	5.4	1.3	1.0	1.1
Cylert^®	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Dexedrine^®	1.4^b	1.1	1.1	0.3	0.3	0.2	1.0	0.9	1.0	1.6^b	1.2	1.2
Dextroamphetamine	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.3	0.3	0.3	0.2	0.3
Didrex^®	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Eskatrol^®	0.1	0.0^a	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0^a	0.1
Ionamin^®	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.2
Mazanor^®	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
Obedrin-LA^®	0.0	0.0	*	0.0	0.1	*	0.0	0.0	*	0.0	*	*
Plegine^®	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
Preludin^®	0.4^a	0.3	0.2	0.0	0.1	0.1	0.1	0.2^a	0.1	0.5^a	0.4	0.3
Sanorex^®	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
Tenuate^®	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine and Phentermine Products^3,4	4.5^b	4.2	4.0	1.5	1.5	1.4	3.4	3.5	3.7	5.1^b	4.7	4.4
Mazindol Products^3,5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0

51020

**Table 3.4A Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Numbers in Thousands, 2002-2004**
Sedative	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methaqualone, Sopor^®, or Quaalude^®	7,320	6,997	7,114	60	64	54	305	258	254	6,955	6,676	6,805
Barbiturates¹	3,375^b	3,301^b	2,603	29	44	37	121	101	118	3,226^b	3,156^b	2,447
Restoril^® or Temazepam	1,003	923	779	48	50	42	108	90	119	847	783	617
Amytal^®	274	209	249	4^a	26	21	21	19	23	249	164	204
Butisol^®	109	103	69	8	15	17	14	12	22	87	76	30
Chloral Hydrate	214	149	220	7	11	19	9	25	11	198	114	190
Dalmane^®	638	435	440	22	23	40	16	19	14	600	393	386
Halcion^®	939	668	674	17	23	34	64	53	55	857^a	592	585
Phenobarbital	1,568^a	1,300	1,132	37	29	25	105	91	82	1,426^a	1,180	1,025
Placidyl^®	1,045	783	885	12	12	4	34^a	14	13	998	758	868
Tuinal^®	1,393^a	1,077	1,021	8	14	8	17	10	11	1,368^a	1,053	1,002
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	2,101^b	1,662	1,492	82	75	95	175	143	173	1,844^b	1,443	1,224
Any Barbiturates^2,4	4,058^a	4,031^a	3,359	73	98	82	209	181	196	3,775^a	3,753^a	3,081

51020

**Table 3.4B Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Percentages, 2002-2004**
Sedative	Total			AGE GROUP
	Total			12-17			18-25			26 or Older
	2002	2003	2004	2002	2003	2004	2002	2003	2004	2002	2003	2004
*Low precision; no estimate reported. ^a Difference between estimate and 2004 estimate is statistically significant at the .05 level. ^b Difference between estimate and 2004 estimate is statistically significant at the .01 level. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methaqualone, Sopor^®, or Quaalude^®	3.1	2.9	3.0	0.2	0.3	0.2	1.0	0.8	0.8	3.9	3.7	3.7
Barbiturates¹	1.4^b	1.4^b	1.1	0.1	0.2	0.1	0.4	0.3	0.4	1.8^b	1.7^b	1.3
Restoril^® or Temazepam	0.4^a	0.4	0.3	0.2	0.2	0.2	0.3	0.3	0.4	0.5^a	0.4	0.3
Amytal^®	0.1	0.1	0.1	0.0^a	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Butisol^®	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0
Chloral Hydrate	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1
Dalmane^®	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2
Halcion^®	0.4^a	0.3	0.3	0.1	0.1	0.1	0.2	0.2	0.2	0.5^a	0.3	0.3
Phenobarbital	0.7^a	0.5	0.5	0.2	0.1	0.1	0.3	0.3	0.3	0.8^a	0.7	0.6
Placidyl^®	0.4	0.3	0.4	0.1	0.0	0.0	0.1^a	0.0	0.0	0.6	0.4	0.5
Tuinal^®	0.6^a	0.5	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.8^a	0.6	0.5
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	0.9^b	0.7	0.6	0.3	0.3	0.4	0.6	0.4	0.5	1.0^b	0.8	0.7
Any Barbiturates^2,4	1.7^a	1.7^a	1.4	0.3	0.4	0.3	0.7	0.6	0.6	2.1^a	2.1^a	1.7

51215

**Table 3.5A Nonmedical Use of Specific Pain Relievers in Lifetime, by Gender and Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Pain Reliever	Total	GENDER		AGE GROUP
Pain Reliever	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	19,366	10,711	8,655	1,490	4,007	13,868
Percocet^®, Percodan^®, or Tylox^®	10,473	6,201	4,272	469	2,517	7,487
Vicodin^®, Lortab^®, or Lorcet^®	15,172	8,417	6,756	1,173	4,736	9,264
Codeine	6,859	4,219	2,640	521	2,005	4,333
Demerol^®	2,788	1,744	1,044	117	656	2,015
Dilaudid^®	963	667	296	12	93	858
Fioricet^®	455	216	239	17	59	379
Fiorinal^®	492	205	287	18	38	436
Hydrocodone	5,398	3,055	2,343	389	1,930	3,079
Methadone	1,131	712	419	116	386	629
Morphine	2,067	1,315	752	230	734	1,103
OxyContin^®	2,609	1,634	975	261	1,114	1,235
Phenaphen^® with Codeine	772	477	294	59	202	511
Propoxyphene	321	160	161	29	71	221
SK-65^®	42	27	15	12	13	16
Stadol^®	148	82	66	5	29	113
Talacen^®	71	45	26	10	17	44
Talwin^®	457	285	172	11	20	425
Talwin^® NX	86	44	42	9	12	65
Tramadol	188	124	64	15	62	111
Ultram^®	1,060	530	530	72	316	672
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	21,049	11,725	9,325	1,697	4,547	14,805
Oxycodone Products^1,3	11,203	6,637	4,566	607	2,873	7,723
Hydrocodone Products^1,4	16,165	8,932	7,233	1,296	5,046	9,823
Tramadol Products^1,5	1,165	594	571	82	353	730

51215

**Table 3.5B Nonmedical Use of Specific Pain Relievers in Lifetime, by Gender and Age Group: Percentages, Annual Averages Based on 2002-2004**
Pain Reliever	Total	GENDER		AGE GROUP
Pain Reliever	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	8.1	9.3	7.1	6.0	12.7	7.7
Percocet^®, Percodan^®, or Tylox^®	4.4	5.4	3.5	1.9	8.0	4.1
Vicodin^®, Lortab^®, or Lorcet^®	6.4	7.3	5.5	4.7	15.0	5.1
Codeine	2.9	3.7	2.2	2.1	6.3	2.4
Demerol^®	1.2	1.5	0.9	0.5	2.1	1.1
Dilaudid^®	0.4	0.6	0.2	0.0	0.3	0.5
Fioricet^®	0.2	0.2	0.2	0.1	0.2	0.2
Fiorinal^®	0.2	0.2	0.2	0.1	0.1	0.2
Hydrocodone	2.3	2.7	1.9	1.6	6.1	1.7
Methadone	0.5	0.6	0.3	0.5	1.2	0.3
Morphine	0.9	1.1	0.6	0.9	2.3	0.6
OxyContin^®	1.1	1.4	0.8	1.0	3.5	0.7
Phenaphen^® with Codeine	0.3	0.4	0.2	0.2	0.6	0.3
Propoxyphene	0.1	0.1	0.1	0.1	0.2	0.1
SK-65^®	0.0	0.0	0.0	0.0	0.0	0.0
Stadol^®	0.1	0.1	0.1	0.0	0.1	0.1
Talacen^®	0.0	0.0	0.0	0.0	0.1	0.0
Talwin^®	0.2	0.2	0.1	0.0	0.1	0.2
Talwin^® NX	0.0	0.0	0.0	0.0	0.0	0.0
Tramadol	0.1	0.1	0.1	0.1	0.2	0.1
Ultram^®	0.4	0.5	0.4	0.3	1.0	0.4
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	8.9	10.2	7.6	6.8	14.4	8.2
Oxycodone Products^1,3	4.7	5.8	3.7	2.4	9.1	4.3
Hydrocodone Products^1,4	6.8	7.8	5.9	5.2	15.9	5.4
Tramadol Products^1,5	0.5	0.5	0.5	0.3	1.1	0.4

51215

**Table 3.6A Nonmedical Use of Specific Tranquilizers in Lifetime, by Gender and Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Tranquilizer	Total	GENDER		AGE GROUP
Tranquilizer	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Klonopin^® or Clonazepam	2,657	1,412	1,244	168	912	1,577
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	9,025	4,417	4,608	438	2,321	6,266
Valium^® or Diazepam	14,555	8,046	6,509	410	2,406	11,738
Atarax^®	283	171	112	22	43	219
BuSpar^®	661	333	328	49	228	383
Equanil^®	94	45	49	12	16	66
Flexeril^®	1,914	913	1,002	43	377	1,494
Librium^®	1,185	643	543	22	75	1,089
Limbitrol^®	84	41	43	10	22	51
Meprobamate	153	98	55	13	15	126
Miltown^®	113	68	45	11	7	95
Rohypnol^®	376	243	134	37	163	176
Serax^®	167	91	75	12	26	129
Soma^®	2,488	1,332	1,156	144	832	1,512
Tranxene^®	182	99	83	11	23	148
Vistaril^®	296	130	166	17	51	228
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	18,569	9,646	8,922	722	3,490	14,357
Meprobamate Products^1,3	314	183	131	31	35	247
Muscle Relaxants^1,4	3,662	1,876	1,786	171	1,030	2,461

51215

**Table 3.6B Nonmedical Use of Specific Tranquilizers in Lifetime, by Gender and Age Group: Percentages, Annual Averages Based on 2002-2004**
Tranquilizer	Total	GENDER		AGE GROUP
Tranquilizer	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Klonopin^® or Clonazepam	1.1	1.2	1.0	0.7	2.9	0.9
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	3.8	3.8	3.8	1.8	7.3	3.5
Valium^® or Diazepam	6.1	7.0	5.3	1.6	7.6	6.5
Atarax^®	0.1	0.1	0.1	0.1	0.1	0.1
BuSpar^®	0.3	0.3	0.3	0.2	0.7	0.2
Equanil^®	0.0	0.0	0.0	0.0	0.0	0.0
Flexeril^®	0.8	0.8	0.8	0.2	1.2	0.8
Librium^®	0.5	0.6	0.4	0.1	0.2	0.6
Limbitrol^®	0.0	0.0	0.0	0.0	0.1	0.0
Meprobamate	0.1	0.1	0.0	0.1	0.0	0.1
Miltown^®	0.0	0.1	0.0	0.0	0.0	0.1
Rohypnol^®	0.2	0.2	0.1	0.1	0.5	0.1
Serax^®	0.1	0.1	0.1	0.0	0.1	0.1
Soma^®	1.0	1.2	0.9	0.6	2.6	0.8
Tranxene^®	0.1	0.1	0.1	0.0	0.1	0.1
Vistaril^®	0.1	0.1	0.1	0.1	0.2	0.1
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	7.8	8.4	7.3	2.9	11.0	7.9
Meprobamate Products^1,3	0.1	0.2	0.1	0.1	0.1	0.1
Muscle Relaxants^1,4	1.5	1.6	1.5	0.7	3.3	1.4

51215

**Table 3.7A Nonmedical Use of Specific Stimulants in Lifetime, by Gender and Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Stimulants	Total	GENDER		AGE GROUP
Stimulants	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	12,138	7,250	4,888	331	1,698	10,109
Prescription Diet Pills²	8,585	4,505	4,080	251	708	7,626
Ritalin^® or Methylphenidate	4,293	2,577	1,716	526	1,732	2,035
Cylert^®	209	137	72	22	36	151
Dexedrine^®	2,803	1,587	1,216	67	309	2,427
Dextroamphetamine	575	334	241	28	80	467
Didrex^®	186	95	91	18	30	138
Eskatrol^®	227	138	89	10	11	206
Ionamin^®	511	291	220	19	21	471
Mazanor^®	54	20	34	13	6	34
Obedrin-LA^®	33	8	24	7	4	23
Plegine^®	46	31	15	10	4	31
Preludin^®	697	447	250	12	37	648
Sanorex^®	116	73	44	18	24	73
Tenuate^®	214	77	137	11	14	189
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	10,059	5,260	4,799	370	1,121	8,568
Mazindol Products^3,5	157	90	66	27	27	103

51215

**Table 3.7B Nonmedical Use of Specific Stimulants in Lifetime, by Gender and Age Group: Percentages, Annual Averages Based on 2002-2004**
Stimulants	Total	GENDER		AGE GROUP
Stimulants	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	5.1	6.3	4.0	1.3	5.4	5.6
Prescription Diet Pills²	3.6	3.9	3.3	1.0	2.2	4.2
Ritalin^® or Methylphenidate	1.8	2.2	1.4	2.1	5.5	1.1
Cylert^®	0.1	0.1	0.1	0.1	0.1	0.1
Dexedrine^®	1.2	1.4	1.0	0.3	1.0	1.3
Dextroamphetamine	0.2	0.3	0.2	0.1	0.3	0.3
Didrex^®	0.1	0.1	0.1	0.1	0.1	0.1
Eskatrol^®	0.1	0.1	0.1	0.0	0.0	0.1
Ionamin^®	0.2	0.3	0.2	0.1	0.1	0.3
Mazanor^®	0.0	0.0	0.0	0.1	0.0	0.0
Obedrin-LA^®	0.0	0.0	0.0	0.0	0.0	0.0
Plegine^®	0.0	0.0	0.0	0.0	0.0	0.0
Preludin^®	0.3	0.4	0.2	0.0	0.1	0.4
Sanorex^®	0.0	0.1	0.0	0.1	0.1	0.0
Tenuate^®	0.1	0.1	0.1	0.0	0.0	0.1
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	4.2	4.6	3.9	1.5	3.5	4.7
Mazindol Products^3,5	0.1	0.1	0.1	0.1	0.1	0.1

51215

**Table 3.8A Nonmedical Use of Specific Sedatives in Lifetime, by Gender and Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Sedative	Total	GENDER		AGE GROUP
Sedative	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003 and 2004.
Methaqualone, Sopor^®, or Quaalude^®	7,144	4,325	2,818	59	272	6,812
Barbiturates¹	3,093	1,985	1,108	37	113	2,943
Restoril^® or Temazepam	901	440	462	47	106	749
Amytal^®	244	185	59	17	21	206
Butisol^®	94	68	26	13	16	64
Chloral Hydrate	194	98	96	12	15	167
Dalmane^®	504	293	211	28	17	459
Halcion^®	760	370	390	25	57	678
Phenobarbital	1,333	776	557	30	93	1,210
Placidyl^®	905	611	293	9	20	875
Tuinal^®	1,164	721	443	10	13	1,141
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	1,751	898	853	84	164	1,504
Any Barbiturates^2,4	3,816	2,360	1,456	84	195	3,537

51215

**Table 3.8B Nonmedical Use of Specific Sedatives in Lifetime, by Gender and Age Group: Percentages, Annual Averages Based on 2002-2004**
Sedative	Total	GENDER		AGE GROUP
Sedative	Total	Male	Female	12 to 17	18 to 25	26 or Older
*Low precision; no estimate reported. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003 and 2004.
Methaqualone, Sopor^®, or Quaalude^®	3.0	3.8	2.3	0.2	0.9	3.8
Barbiturates¹	1.3	1.7	0.9	0.1	0.4	1.6
Restoril^® or Temazepam	0.4	0.4	0.4	0.2	0.3	0.4
Amytal^®	0.1	0.2	0.0	0.1	0.1	0.1
Butisol^®	0.0	0.1	0.0	0.1	0.1	0.0
Chloral Hydrate	0.1	0.1	0.1	0.0	0.0	0.1
Dalmane^®	0.2	0.3	0.2	0.1	0.1	0.3
Halcion^®	0.3	0.3	0.3	0.1	0.2	0.4
Phenobarbital	0.6	0.7	0.5	0.1	0.3	0.7
Placidyl^®	0.4	0.5	0.2	0.0	0.1	0.5
Tuinal^®	0.5	0.6	0.4	0.0	0.0	0.6
SELECTED GROUPS OF DRUGS
Temazepam, Flurazepam, or Triazolam^2,3	0.7	0.8	0.7	0.3	0.5	0.8
Any Barbiturates^2,4	1.6	2.1	1.2	0.3	0.6	2.0

51117

**Table 3.9A Nonmedical Use of Specific Prescription Pain Relievers among Lifetime Users of Any Pain Reliever, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Pain Reliever	TOTAL	AGE GROUP
Pain Reliever	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY PAIN RELIEVER	30,862	2,817	7,393	20,652
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	19,366	1,490	4,007	13,868
Percocet^®, Percodan^®, or Tylox^®	10,473	469	2,517	7,487
Vicodin^®, Lortab^®, or Lorcet^®	15,172	1,173	4,736	9,264
Codeine	6,859	521	2,005	4,333
Demerol^®	2,788	117	656	2,015
Dilaudid^®	963	12	93	858
Fioricet^®	455	17	59	379
Fiorinal^®	492	18	38	436
Hydrocodone	5,398	389	1,930	3,079
Methadone	1,131	116	386	629
Morphine	2,067	230	734	1,103
OxyContin^®	2,609	261	1,114	1,235
Phenaphen^® with Codeine	772	59	202	511
Propoxyphene	321	29	71	221
SK-65^®	42	12	13	16
Stadol^®	148	5	29	113
Talacen^®	71	10	17	44
Talwin^®	457	11	20	425
Talwin^® NX	86	9	12	65
Tramadol	188	15	62	111
Ultram^®	1,060	72	316	672
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	21,049	1,697	4,547	14,805
Oxycodone Products^1,3	11,203	607	2,873	7,723
Hydrocodone Products^1,4	16,165	1,296	5,046	9,823
Tramadol Products^1,5	1,165	82	353	730

51117

**Table 3.9B Nonmedical Use of Specific Prescription Pain Relievers among Lifetime Users of Any Pain Reliever, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Pain Reliever	TOTAL	AGE GROUP
Pain Reliever	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of lifetime nonmedical users of any prescription pain reliever. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY PAIN RELIEVER	100.0	100.0	100.0	100.0
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	62.7	52.9	54.2	67.2
Percocet^®, Percodan^®, or Tylox^®	33.9	16.7	34.0	36.3
Vicodin^®, Lortab^®, or Lorcet^®	49.2	41.6	64.1	44.9
Codeine	22.2	18.5	27.1	21.0
Demerol^®	9.0	4.2	8.9	9.8
Dilaudid^®	3.1	0.4	1.3	4.2
Fioricet^®	1.5	0.6	0.8	1.8
Fiorinal^®	1.6	0.6	0.5	2.1
Hydrocodone	17.5	13.8	26.1	14.9
Methadone	3.7	4.1	5.2	3.0
Morphine	6.7	8.2	9.9	5.3
OxyContin^®	8.5	9.3	15.1	6.0
Phenaphen^® with Codeine	2.5	2.1	2.7	2.5
Propoxyphene	1.0	1.0	1.0	1.1
SK-65^®	0.1	0.4	0.2	0.1
Stadol^®	0.5	0.2	0.4	0.5
Talacen^®	0.2	0.4	0.2	0.2
Talwin^®	1.5	0.4	0.3	2.1
Talwin^® NX	0.3	0.3	0.2	0.3
Tramadol	0.6	0.5	0.8	0.5
Ultram^®	3.4	2.5	4.3	3.3
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	68.2	60.2	61.5	71.7
Oxycodone Products^1,3	36.3	21.5	38.9	37.4
Hydrocodone Products^1,4	52.4	46.0	68.2	47.6
Tramadol Products^1,5	3.8	2.9	4.8	3.5

51117

**Table 3.10A Nonmedical Use of Specific Prescription Pain Relievers among Past Year Initiates of Any Pain Reliever, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Pain Reliever	TOTAL	AGE GROUP
Pain Reliever	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY PAIN RELIEVER	2,399	902	881	615
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	822	362	255	205
Percocet^®, Percodan^®, or Tylox^®	426	143	190	93
Vicodin^®, Lortab^®, or Lorcet^®	1,207	433	499	274
Codeine	328	163	141	25
Demerol^®	69	21	35	13
Dilaudid^®	8	3	2	*
Fioricet^®	8	3	5	0
Fiorinal^®	10	6	1	3
Hydrocodone	369	134	146	89
Methadone	52	29	14	9
Morphine	109	63	34	12
OxyContin^®	170	78	78	14
Phenaphen^® with Codeine	23	15	8	1
Propoxyphene	10	5	2	3
SK-65^®	4	3	1	*
Stadol^®	1	*	0	1
Talacen^®	6	4	2	*
Talwin^®	2	1	1	*
Talwin^® NX	3	2	0	*
Tramadol	12	2	6	*
Ultram^®	55	18	18	*
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	997	443	332	222
Oxycodone Products^1,3	528	188	239	101
Hydrocodone Products^1,4	1,368	486	556	326
Tramadol Products^1,5	67	21	23	23

51117

**Table 3.10B Nonmedical Use of Specific Prescription Pain Relievers among Past Year Initiates of Any Pain Reliever, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Pain Reliever	TOTAL	AGE GROUP
Pain Reliever	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of persons who initiated nonmedical use of any prescription pain reliever in the past 12 months. ¹ Includes other-specify drug responses that are not asked about explicitly in the pain relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY PAIN RELIEVER	100.0	100.0	100.0	100.0
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	34.3	40.1	28.9	33.3
Percocet^®, Percodan^®, or Tylox^®	17.8	15.9	21.5	15.2
Vicodin^®, Lortab^®, or Lorcet^®	50.3	48.0	56.6	44.6
Codeine	13.7	18.0	16.0	4.0
Demerol^®	2.9	2.3	4.0	2.1
Dilaudid^®	0.3	0.4	0.3	*
Fioricet^®	0.3	0.4	0.5	0.0
Fiorinal^®	0.4	0.7	0.1	0.5
Hydrocodone	15.4	14.9	16.5	14.5
Methadone	2.2	3.2	1.6	1.5
Morphine	4.5	6.9	3.9	2.0
OxyContin^®	7.1	8.7	8.8	2.3
Phenaphen^® with Codeine	1.0	1.6	0.9	0.1
Propoxyphene	0.4	0.6	0.3	0.5
SK-65^®	0.2	0.3	0.1	*
Stadol^®	0.0	*	0.0	0.1
Talacen^®	0.2	0.5	0.2	*
Talwin^®	0.1	0.1	0.1	*
Talwin^® NX	0.1	0.3	0.0	*
Tramadol	0.5	0.3	0.7	*
Ultram^®	2.3	2.0	2.1	*
SELECTED GROUPS OF DRUGS
Propoxyphene or Codeine Products^1,2	41.6	49.1	37.6	36.1
Oxycodone Products^1,3	22.0	20.8	27.1	16.4
Hydrocodone Products^1,4	57.0	53.9	63.1	53.0
Tramadol Products^1,5	2.8	2.3	2.7	3.8

51117

**Table 3.11A Nonmedical Use of Specific Prescription Tranquilizers among Lifetime Users of Any Tranquilizer, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Tranquilizer	TOTAL	AGE GROUP
Tranquilizer	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY TRANQUILIZER	19,780	842	3,763	15,175
Klonopin^® or Clonazepam	2,657	168	912	1,577
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	9,025	438	2,321	6,266
Valium^® or Diazepam	14,555	410	2,406	11,738
Atarax^®	283	22	43	219
BuSpar^®	661	49	228	383
Equanil^®	94	12	16	66
Flexeril^®	1,914	43	377	1,494
Librium^®	1,185	22	75	1,089
Limbitrol^®	84	10	22	51
Meprobamate	153	13	15	126
Miltown^®	113	11	7	95
Rohypnol^®	376	37	163	176
Serax^®	167	12	26	129
Soma^®	2,488	144	832	1,512
Tranxene^®	182	11	23	148
Vistaril^®	296	17	51	228
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	18,569	722	3,490	14,357
Meprobamate Products^1,3	314	31	35	247
Muscle Relaxants^1,4	3,662	171	1,030	2,461

51117

**Table 3.11B Nonmedical Use of Specific Prescription Tranquilizers among Lifetime Users of Any Tranquilizer, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Tranquilizer	TOTAL	AGE GROUP
Tranquilizer	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of lifetime nonmedical users of any prescription tranquilizer. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY TRANQUILIZER	100.0	100.0	100.0	100.0
Klonopin^® or Clonazepam	13.4	19.9	24.2	10.4
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	45.6	52.1	61.7	41.3
Valium^® or Diazepam	73.6	48.7	63.9	77.4
Atarax^®	1.4	2.6	1.1	1.4
BuSpar^®	3.3	5.8	6.1	2.5
Equanil^®	0.5	1.4	0.4	0.4
Flexeril^®	9.7	5.1	10.0	9.8
Librium^®	6.0	2.6	2.0	7.2
Limbitrol^®	0.4	1.2	0.6	0.3
Meprobamate	0.8	1.5	0.4	0.8
Miltown^®	0.6	1.3	0.2	0.6
Rohypnol^®	1.9	4.4	4.3	1.2
Serax^®	0.8	1.4	0.7	0.8
Soma^®	12.6	17.1	22.1	10.0
Tranxene^®	0.9	1.3	0.6	1.0
Vistaril^®	1.5	2.1	1.4	1.5
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	93.9	85.8	92.7	94.6
Meprobamate Products^1,3	1.6	3.7	0.9	1.6
Muscle Relaxants^1,4	18.5	20.3	27.4	16.2

51117

**Table 3.12A Nonmedical Use of Specific Prescription Tranquilizers among Past Year Initiates of Any Tranquilizer, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Tranquilizer	TOTAL	AGE GROUP
Tranquilizer	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY TRANQUILIZER	1,145	315	431	400
Klonopin^® or Clonazepam	167	48	68	50
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	583	155	230	198
Valium^® or Diazepam	481	134	194	154
Atarax^®	13	7	6	*
BuSpar^®	37	16	13	8
Equanil^®	7	5	1	*
Flexeril^®	80	14	20	45
Librium^®	15	10	4	*
Limbitrol^®	2	0	1	*
Meprobamate	6	4	0	*
Miltown^®	4	4	*	*
Rohypnol^®	14	11	3	*
Serax^®	4	4	*	*
Soma^®	147	45	66	36
Tranxene^®	7	2	3	*
Vistaril^®	13	7	4	*
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	979	262	378	339
Meprobamate Products^1,3	15	12	2	*
Muscle Relaxants^1,4	211	59	78	75

51117

**Table 3.12B Nonmedical Use of Specific Prescription Tranquilizers among Past Year Initiates of Any Tranquilizer, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Tranquilizer	TOTAL	AGE GROUP
Tranquilizer	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of persons who initiated nonmedical use of any prescription tranquilizer in the past 12 months. ¹ Includes other-specify drug responses that are not asked about explicitly in the tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^®, or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY TRANQUILIZER	100.0	100.0	100.0	100.0
Klonopin^® or Clonazepam	14.5	15.3	15.9	12.5
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	50.9	49.4	53.3	49.4
Valium^® or Diazepam	42.0	42.6	44.9	38.5
Atarax^®	1.1	2.1	1.4	*
BuSpar^®	3.2	5.0	3.1	2.0
Equanil^®	0.6	1.6	0.3	*
Flexeril^®	7.0	4.5	4.7	11.3
Librium^®	1.3	3.3	0.8	*
Limbitrol^®	0.1	0.1	0.3	*
Meprobamate	0.5	1.3	0.1	*
Miltown^®	0.4	1.4	*	*
Rohypnol^®	1.2	3.4	0.7	*
Serax^®	0.3	1.1	*	*
Soma^®	12.8	14.2	15.4	9.0
Tranxene^®	0.6	0.6	0.6	*
Vistaril^®	1.1	2.2	0.9	*
SELECTED GROUPS OF DRUGS
Benzodiazepines^1,2	85.5	83.3	87.7	84.8
Meprobamate Products^1,3	1.3	3.8	0.5	*
Muscle Relaxants^1,4	18.5	18.6	18.1	18.7

51117

**Table 3.13A Nonmedical Use of Specific Prescription Stimulants among Lifetime Users of Any Stimulant, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Stimulant	TOTAL	AGE GROUP
Stimulant	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY STIMULANT	20,617	983	3,395	16,239
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	12,138	331	1,698	10,109
Prescription Diet Pills²	8,585	251	708	7,626
Ritalin^® or Methylphenidate	4,293	526	1,732	2,035
Cylert^®	209	22	36	151
Dexedrine^®	2,803	67	309	2,427
Dextroamphetamine	575	28	80	467
Didrex^®	186	18	30	138
Eskatrol^®	227	10	11	206
Ionamin^®	511	19	21	471
Mazanor^®	54	13	6	34
Obedrin-LA^®	33	7	4	23
Plegine^®	46	10	4	31
Preludin^®	697	12	37	648
Sanorex^®	116	18	24	73
Tenuate^®	214	11	14	189
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	10,059	370	1,121	8,568
Mazindol Products^3,5	157	27	27	103

51117

**Table 3.13B Nonmedical Use of Specific Prescription Stimulants among Lifetime Users of Any Stimulant, by Age Group: Percentages, Annual Averages Based on 2002-2004**
Stimulant	TOTAL	AGE GROUP
Stimulant	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. NOTE: The denominator for percentages is the total number of lifetime nonmedical users of any prescription stimulant or methamphetamine. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY STIMULANT	100.0	100.0	100.0	100.0
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	58.9	33.7	50.0	62.2
Prescription Diet Pills²	41.6	25.6	20.9	47.0
Ritalin^® or Methylphenidate	20.8	53.6	51.0	12.5
Cylert^®	1.0	2.3	1.1	0.9
Dexedrine^®	13.6	6.8	9.1	14.9
Dextroamphetamine	2.8	2.8	2.4	2.9
Didrex^®	0.9	1.8	0.9	0.8
Eskatrol^®	1.1	1.0	0.3	1.3
Ionamin^®	2.5	1.9	0.6	2.9
Mazanor^®	0.3	1.4	0.2	0.2
Obedrin-LA^®	0.2	0.7	0.1	0.1
Plegine^®	0.2	1.0	0.1	0.2
Preludin^®	3.4	1.2	1.1	4.0
Sanorex^®	0.6	1.9	0.7	0.5
Tenuate^®	1.0	1.1	0.4	1.2
SELECTED GROUPS OF DRUGS
Amphetamine, Dextroamphetamine, and Phentermine Products^3,4	48.8	37.6	33.0	52.8
Mazindol Products^3,5	0.8	2.8	0.8	0.6

51117

**Table 3.14A Nonmedical Use of Specific Prescription Stimulants among Past Year Initiates of Any Stimulant, by Age Group: Numbers in Thousands, Annual Averages Based on 2002-2004**
Stimulant	TOTAL	AGE GROUP
Stimulant	TOTAL	12-17	18-25	26 or Older
*Low precision; no estimate reported. ¹ Also known as crank, crystal, ice, or speed. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. Source: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2002, 2003, and 2004.
ANY STIMULANT	764	301	307	*
Methamphetamine,¹ Desoxyn^®, or Methedrine^®	240	94	97	*
Prescription Diet Pills²	157	70	53	*
Ritalin^® or Methylphenidate	323	143	125	*
Cylert^®	5	3	1	*
Dexedrine^®	38	16	18	*
Dextroamphetamine	10	4	3	*
Didrex^®	10	4	1	*
Eskatrol^®	6	3	1	*

Appendix D: Selected Data Tables